Navigation Links
Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
Date:1/7/2008

the Phase 1 combination study and/or our development of R7128, including the risk that we will fail to release final safety and efficacy data from a Phase 1, Part 3 multiple ascending dose study and the risk that we will fail to initiate a Phase 2b combination study of R7128 with Pegasys plus Copegus in the second calendar half of 2008, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2007 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
2. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
5. Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
6. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
9. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
10. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
11. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... MOUNTAIN VIEW, Calif. , Sept. 1, ... of the cardiovascular image management market, Frost ... with the 2015 European Frost & Sullivan ... Netherlands -based PMI has designed innovative ... product lines—which deliver precise and reproducible quantitative ...
(Date:9/1/2015)... 1, 2015  Abbott (NYSE: ABT ) announced today ... randomized trial comparing the safety and effectiveness of Abbott,s ... , Abbott,s market-leading, permanent drug eluting stent. The trial ... and enrolled 400 people with coronary artery ... results will be featured at a late-breaking session today ...
(Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
Breaking Medicine Technology:Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4BerGenBio Appoints Non-Executive Directors 2
(Date:9/1/2015)... ... September 01, 2015 , ... A new episode of “Voices In ... a look at the topic of arthritis. There are over 100 different types of ... arthritis types and statistics in an effort to shed light on this important topic. ...
(Date:9/1/2015)... ON (PRWEB) , ... September 01, 2015 , ... ... Secrets, a leading retailer of professional hair salons. This highly anticipated partnership between ... of the Curl Keeper™ Styling Collection. Founder Jonathan Torch and the Curly Hair ...
(Date:8/31/2015)... ... 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics proudly announces that Kathy ... by Modern Luxury’s The Atlantan Magazine. , This award for the Sculpted ... Her idea and vision to bring to Atlanta a true luxury experience in ...
(Date:8/31/2015)... ... ... it comes to undergoing a hair transplant, most patients have donor hair moved from one ... the hair on top of the scalp, as well as filling in areas missing hair, ... on other areas of their head. , What about patients who have a limited, or ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s ... that is unique to the Lake Orion area. This program is one of ... , WEmovestrong’s weight management program will incorporate group fitness and nutritional consultations to ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2
... children with tooth decay may be more likely to be ... weight, are more likely to consume too many calories, a ... The Endocrine Society,s 92nd Annual Meeting in San Diego. ... decay and obesity in preschoolers," the study,s lead author, Kathleen ...
... at increased risk of obesity, but a new study shows ... preschoolers and their parents helps the children reduce body fat ... The Endocrine Society,s 92nd Annual Meeting in San Diego. ... obesity epidemic, the study,s lead author Jardena Puder, MD, said. ...
... , ... Angeles dentist, is proud to announce the opening of his new office in North Hollywood. Many ... staff in North Hollywood, CA. , ... June 22, 2010 -- Dr. Bijan Afar, well-respected Los Angeles dentist , is proud to ...
... ... million gift to help fund the construction of its new home at the UCSF Mission ... ... gift to help fund the construction of its new home at the UCSF Mission Bay ...
... ... announced the following organizations will use SeeMyRadiology.com for medical image exchange with outside ... ... ( http://www.SeeMyRadiology.com ), Accelarad’s online medical image cloud computing service, today announced the ...
... ... the organization targets an audience of teens and young adults in an effort to empower ... cancer. , ... 22, 2010 -- Kids Into Safe Skin (K.I.S.S) announced today the official launch of its ...
Cached Medicine News:Health News:Study shows a possible link between preschoolers' cavities and excess body fat 2Health News:Lifestyle intervention reduces preschoolers' body fat, improves fitness 2Health News:Trusted Los Angeles Dentist, Dr. Bijan Afar, is Now Practicing in Hollywood Area 2Health News:Trusted Los Angeles Dentist, Dr. Bijan Afar, is Now Practicing in Hollywood Area 3Health News:UCSF Children's Hospital Receives $100 Million Gift To Build New Hospital 2Health News:UCSF Children's Hospital Receives $100 Million Gift To Build New Hospital 3Health News:UCSF Children's Hospital Receives $100 Million Gift To Build New Hospital 4Health News:UCSF Children's Hospital Receives $100 Million Gift To Build New Hospital 5Health News:Accelarad Announces Six New SeeMyRadiology.com Customers Seeking Fast, Secure and Innovative Medical Image Exchange Solution 2Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 2Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 3Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: